Literature DB >> 24573799

Infrared multiple-photon dissociation spectroscopy of deprotonated 6-hydroxynicotinic acid.

Michael J van Stipdonk1, Michael J Kullman, Giel Berden, Jos Oomens.   

Abstract

RATIONALE: Hydroxynicotinic acids (2-, 4-, 5- and 6-hydroxy) are widely used in the manufacture of industrial products, and hydroxypyridines are important model systems for study of the tautomerization of N-heterocyclic compounds. Here we determined the gas-phase structure of deprotonated 6-hydroxynicotinic acid (6OHNic).
METHODS: Anions were generated by electrospray ionization, and isolated and stored in a Fourier transform ion cyclotron resonance mass spectrometer. Infrared (action) spectra were collected by monitoring photodissociation yield versus photon energy. Experimental spectra were then compared with those predicted by density functional theory (DFT) and second-order Møller-Plesset (MP2) perturbation theory calculations.
RESULTS: For neutral 6OHNic, DFT and MP2 calculations strongly suggest that the 6-pyridone tautomer is favored when solvent effects are included. The lowest energy isomer of deprotonated 6OHNic, in the aqueous or gas phase, is predicted to be the 6-pyridone structure deprotonated by the carboxylic acid group.
CONCLUSIONS: The deprotonated, 6-pyridone structure is confirmed by comparison of the infrared multiple-photon photodissociation (IRMPD) spectrum in the region of 1100-1900 cm(-1) with those predicted using DFT and MP2 calculations.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Year:  2014        PMID: 24573799     DOI: 10.1002/rcm.6829

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN: 0951-4198            Impact factor:   2.419


  1 in total

1.  Comment on: "Quantum Chemical Mass Spectrometry: Verification and Extension of the Mobile Proton Model for Histidine" by Julie Cautereels and Frank Blockhuys, J. Am. Soc. Mass Spectrom. 28, 1227-1235 (2017).

Authors:  Benjamin J Bythell
Journal:  J Am Soc Mass Spectrom       Date:  2017-12       Impact factor: 3.109

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.